-
1دورية أكاديمية
المؤلفون: Soria, J.-C.1, DeBraud, F.2, Bahleda, R.1, Adamo, B.3, Andre, F.1, Dientsmann, R.3,4, Delmonte, A.2, Cereda, R.5,6,7, Isaacson, J.5,6,7, Litten, J.5,6,7, Allen, A.5,6,7, Dubois, F.8, Saba, C.8, Robert, R.8, D'Incalci, M.9, Zucchetti, M.9, Camboni, M. G.5,6,7, Tabernero, J.3
المصدر: Annals of Oncology. Nov2014, Vol. 25 Issue 11, p2244-2251. 8p. 1 Black and White Photograph, 4 Charts, 3 Graphs.
مصطلحات موضوعية: *PHARMACOKINETICS, *PHARMACODYNAMICS, *TUMOR treatment, *FIBROBLAST growth factors, *FIBROBLAST growth factor receptors, *NEOVASCULARIZATION
-
2دورية أكاديمية
المؤلفون: Laguna Montes, J.C.1 (AUTHOR), Pastor, B.1 (AUTHOR), Moreno, L.2 (AUTHOR), Albarran Artahona, V.M.1 (AUTHOR), Potrony, M.3 (AUTHOR), Sánchez, A.3 (AUTHOR), Grau, E.2 (AUTHOR), Gonzalez-Aguado, L.1 (AUTHOR), Oriola, J.3 (AUTHOR), Reyes, R.1 (AUTHOR), Martínez, D.4 (AUTHOR), Vinolas Segarra, N.1 (AUTHOR), Gaba, L.1 (AUTHOR), Adamo, B.1 (AUTHOR), Reguart Aransay, N.1 (AUTHOR), Puig-Butillé, J.A.3 (AUTHOR), Teixido, C.4 (AUTHOR), Mezquita, L.1 (AUTHOR)
المصدر: Annals of Oncology. 2022 Supplement 2, Vol. 33, pS95-S95. 1p.
مصطلحات موضوعية: *CANCER genes, *LUNG cancer, *GERM cells, *FAMILIES
-
3
المؤلفون: Lourdes Calvo, Brandy Pitcher, Chun-Yang Fan, Álvaro Rodríguez-Lescure, Lisa A. Carey, Blanca Munárriz, William T. Barry, Eric P. Winer, Eva Carrasco, Marc L. Citron, Aleix Prat, Nuria Ribelles, Maggie C.U. Cheang, Elaine R. Mardis, MC Liu, Manuel Ruiz-Borrego, Jose Ignacio Chacon, A. Arcusa, Rafael Caballero, Joan Albanell, E. Alba, Tammi L. Vickery, Matthew J. Ellis, Joel S. Parker, A. Lluch, Clifford A. Hudis, Yufeng Li, Miguel Angel Seguí-Palmer, Ángel L Guerrero, Barbara Adamo, Arrate Plazaola, Margaret L. Gulley, Miguel Martin, Octavio Burgues, José A. López, Maria Vidal, Zhiyuan Hu, Charles M. Perou
المساهمون: Universitat de Barcelona, [Prat,A, Adamo,B, Vidal,M.J] Translational Genomics Group, Vall D'Hebron Institute of Oncology (VHIO) Barcelona, Spain. [Prat,A] Department of Medicine, Universitat Autònoma de Barcelona, Spain. [Lluch,A, Burgues,O] Department of Medical Oncology, Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. [Albanell,J] Department of Medical Oncology, Hospital Del Mar, IMIM, Barcelona, Spain. [Albanell,J] Department of Medical Oncology, Universitat Pompeu Fabra (UPF), Barcelona, Spain. [Barry,W.T] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, United States. [Fan,C, Parker,J.S, Cheang,M.C.U, Li,Y, Hu,Z, Gulley,M.L, Carey,L.A, Perou,C.M] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States. [Chacón,J.I] Department of Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain. [Parker,J.S, Perou,C.M] Department of Genetics, University of North Carolina, Chapel Hill, NC, United States. [Calvo,L] Department of Medical Oncology, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain. [Plazaola,A] Department of Medical Oncology, Onkologikoa, San-Sebastián, Spain. [Arcusa,A] Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain. [Seguí-Palmer,M.A] Department of Medical Oncology, Corporació Sanitària Parc Taulí, Sabadell, Spain. [Ribelles,N, Alba,E] Department of Medical Oncology, Department of Pathology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Rodríguez-Lescure,A] Department of Medical Oncology, Hospital General de Elche, Alicante, Spain. [Guerrero,A] Department of Medical Oncology, Instituto Valenciano de Oncología (IVO), Valencia, Spain. [Ruiz-Borrego,M] Department of Medical Oncology, Hospital Universitario Virgen Del Rocío, Sevilla, Spain. [Munarriz,B] Department of Medical Oncology, Hospital Universitario la Fe, Valencia, Spain. [López,J.A] Department of Medical Oncology, Hospital San Camilo, Madrid, Spain.[Pitcher,B.N] Alliance Statistical and Data Center, Duke University, Durham, NC, United States. [Liu,M.C] Department of Oncology, Mayo Clinic, Rochester, MN, United States. [Citron,M.L] ProHEALTH Care Assoc., LLP, Lake Success, NY, United States. [Ellis,M.J, Mardis,E, Vickery,T] Department of Oncology, Washington University St. Louis, MO, United States. [Hudis,C.A] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States. [Winer,E.P] Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. [Caballero,R, Carrasco,E, Martín,M] GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. [Martín,M] Department of Medical Oncology, Instituto de Investigación Sanitaria, Hospital Universitario Gregorio Marañón, Madrid, Spain. [Perou,C.M] Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, United States., This work was supported by funds from the NCI Breast SPORE program Grant No. P50-CA58223-09A1 (CMP), by RO1-CA138255 (CMP), by the Breast Cancer Research Foundation (CMP and MJE), National Cancer Institute (NCI) Strategic Partnering to Evaluate Cancer Signatures Grant No. U01 CA114722-01 (MJE), by the Sociedad Española de Oncología Médica (AP), by FEDER (RETICC-RD12/0036/0051, RD12/0036/0042, RD12/0036/0076, RD12/0036/0070), by Instituto de Salud Carlos III—PI13/01718 (AP), by Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (AP) and by the Alliance Statistics and Data Center (U10-CA33601).
المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
BRITISH JOURNAL OF CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
British Journal of Cancerمصطلحات موضوعية: Oncology, Cancer Research, Análisis de supervivencia, Colorectal cancer, Triple Negative Breast Neoplasms, Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], chemotherapy, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Cohort Studies, Prostate cancer, 0302 clinical medicine, Clinical trials, Breast cancer, Quimioteràpia, Triple-negative breast cancer, Subtypes, 0303 health sciences, Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Survival Analysis [Medical Subject Headings], subtypes, Genomics, Middle Aged, 3. Good health, Treatment Outcome, Estudi de casos, 030220 oncology & carcinogenesis, Female, Neoadjuvant, Basal like, intrinsic, medicine.medical_specialty, Antineoplastic Agents, basal like, Càncer de mama, 03 medical and health sciences, breast cancer, Internal medicine, genomics, medicine, Humans, Chemotherapy, Lung cancer, Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings], Survival analysis, 030304 developmental biology, Proportional hazards model, business.industry, neoadjuvant, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [Medical Subject Headings], Neoplasias de la mama triple negativas, Antineoplásicos, medicine.disease, Survival Analysis, Expressió gènica, Intrisic, Check Tags::Female [Medical Subject Headings], Intrinsic, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies [Medical Subject Headings], Clinical Study, Gene expression, Case studies, Resultado del tratamiento, Health Care::Health Services Administration::Quality of Health Care::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome [Medical Subject Headings], Skin cancer, business, Assaigs clínics
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::688ea1cdfb20f095a971840b89349431Test
https://ddd.uab.cat/record/185079Test -
4
المؤلفون: Pietro Gambadauro, Barbara Adamo, Nerina Denaro, N. Caristi, V. Adamo, G. Chiofalo, Tindara Franchina, Antonio Russo, A. Scimone, Antonio Giordano
المساهمون: Adamo, V, Franchina, T, Adamo, B, Denaro, N, Gambadauro, P, Chiofalo, G, Scimone, A, Caristi, N, Russo, A, Giordano, A
المصدر: Università degli Studi di Siena-IRIS
ResearcherIDمصطلحات موضوعية: Drug, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, molecular markers, media_common.quotation_subject, gefitinib, Antineoplastic Agents, Gefitinib,cancer therapy, Gefitinib, Carcinoma, Non-Small-Cell Lung, Internal medicine, tyrosine kinase inhibitors, medicine, Animals, Humans, non-small cell lung cancer (NSCLC), epidermal growth factor receptor (HER1/EGFR), target therapy, EGFR mutations, Epidermal growth factor receptor, Lung cancer, media_common, Pharmacology, Clinical Trials as Topic, biology, business.industry, medicine.disease, ErbB Receptors, Quinazolines, biology.protein, Molecular Medicine, Signal transduction, business, Biomarkers, Egfr tyrosine kinase, Signal Transduction, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d9f118025ebbed7c303fe673711d876Test
http://hdl.handle.net/11570/10134Test -
5
المؤلفون: Kepa Amillano, Patricia Villagrasa, Ana López-González, Eva Ciruelos, Laia Paré, Xavier Gonzalez, Patricia Galván, Tomás Pascual, Barbara Adamo, Laura Murillo, Maria Vidal, Patricia Gómez-Pardo, Aleix Prat, Blanca Gonzalez-Farre, Meritxell Bellet, Salvador Blanch, José A. Pérez Fidalgo, Noelia Martínez, Jordi Canes
المساهمون: [Adamo B, Vidal M] Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain. [Bellet M, Gómez-Pardo P] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Paré L] Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Pascual T] Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Pérez Fidalgo JA] Hospital Clínico Universitario de Valencia, Valencia, Spain. INCLIVA Instituto de Investigación Sanitaria, Universitat de València, Valencia, Spain. Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Madrid, Spain, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
Recercat. Dipósit de la Recerca de Catalunya
instname
Breast Cancer Research : BCR
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Dipòsit Digital de la UB
Universidad de Barcelona
Breast Cancer Research, Vol 21, Iss 1, Pp 1-12 (2019)مصطلحات موضوعية: Oncology, compuestos heterocíclicos::alcaloides::alcaloides de indol::alcaloides de secologanina y triptamina::alcaloides de la vinca::vinorelbina [COMPUESTOS QUÍMICOS Y DROGAS], Receptors, Steroid, Receptor, ErbB-2, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Gene Expression, factores biológicos::biomarcadores::marcadores tumorales [COMPUESTOS QUÍMICOS Y DROGAS], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Medicaments antineoplàstics, Breast cancer, 0302 clinical medicine, Surgical oncology, Antineoplastic Combined Chemotherapy Protocols, Càncer, Cancer, Otros calificadores::Otros calificadores::/tratamiento farmacológico [Otros calificadores], Aged, 80 and over, 0303 health sciences, Letrozole, Vinorelbine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Postmenopause, Hormone receptor, 030220 oncology & carcinogenesis, Female, Lung cancer, Research Article, medicine.drug, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Heterocyclic Compounds::Alkaloids::Indole Alkaloids::Secologanin Tryptamine Alkaloids::Vinca Alkaloids::Vinorelbine [CHEMICALS AND DRUGS], Breast Neoplasms, lcsh:RC254-282, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, Window of opportunity, Statistical significance, Internal medicine, Progesterone receptor, Biomarkers, Tumor, medicine, Humans, Metronomic, Biological Factors::Biomarkers::Biomarkers, Tumor [CHEMICALS AND DRUGS], Adverse effect, Aged, 030304 developmental biology, business.industry, Marcadors tumorals, Neoplasias::Neoplasias por Localización::Neoplasias de la Mama [ENFERMEDADES], medicine.disease, Antineoplastic Agents, Phytogenic, Compuestos Heterocíclicos::Alcaloides::Alcaloides Indólicos::Alcaloides de Triptamina Secologanina::Alcaloides de la Vinca::Vinorelbina [COMPUESTOS QUÍMICOS Y DROGAS], Administration, Metronomic, Mama - Càncer - Tractament, Càncer de pulmó, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58089687f20745c36ccca57505eb7ae5Test
http://hdl.handle.net/11351/5073Test